What Does the Historical and Current Veterinary Anti-infectives Market Size Trend Indicate?
The veterinary anti-infectives market has seen considerable growth due to a variety of factors.
• The market size for veterinary anti-infectives has seen significant growth in the past few years. The market is projected to expand from $5.54 billion in 2024 to $6.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%.
The past progress in this market can be attributed to the rise in pet ownership, the prevalence of infectious diseases, advances in veterinary medicine, growing awareness, and government initiatives.
How Will the Veterinary Anti-infectives Market Size Evolve over the Forecast Period?
The veterinary anti-infectives market is expected to maintain its strong growth trajectory in upcoming years.
• The market for veterinary anti-infectives is predicted to experience robust growth in the upcoming years, reaching a value of $8.74 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%.
The projected growth throughout the forecast period can be credited to factors such as the persistent increase in pet population, the rise of zoonotic diseases, the expanding global trade in pets, and higher veterinary healthcare spending. Key trends for the forecast period encompass technological progress, a surge in the adoption of biologicals, the incorporation of telehealth into veterinary care, an emphasis on herbal and natural alternatives, the broadening of e-commerce in the veterinary pharmaceutical segment, and strategic collaborations and partnerships.
What Are The Core Factors Supporting Growth In The Veterinary Anti-infectives Market?
The rise in people owning pets is projected to fuel the expansion of the veterinary anti-infectives market. Owning a pet, whether it be a dog, cat, or another domestic animal, is becoming increasingly popular, especially among the younger demographic who view their pets as family members. Some people take in pets due to their loyalty, the companionship they offer, and their ability to alleviate feelings of loneliness. For instance, data put forth by the Australia-based NGO, Animal Medicines Australia, indicates a substantial rise in pet ownership in the country in 2022. The figures reveal that the number of pet owners escalated to 28,730.8 in 2022, a significant increase from 39% in the previous year, equivalent to a 24% growth rate. This surge underscores the escalating trend of adopting and investing in pet care within Australian homes. As a result, the upsurge in pet ownership is proving to be a major driver for the veterinary anti-infectives market.
What Are The Major Segments Within The Global Veterinary Anti-infectives Market?
The veterinary anti-infectives market covered in this report is segmented –
1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes
2) By Species Type: Livestock Animals, Companion Animals
3) By Mode Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels
Subsegments:
1) By Antimicrobial Agents: Antibiotics, Antiseptics
2) By Antiviral Agents: Vaccines, Antiviral Medications
3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals
4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants
Pre-Book The Veterinary Anti-infectives Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Veterinary Anti-infectives Market?
The emerging trend of technological progress is making an influential mark in the veterinary anti-infectives industry. To maintain their market positions, leading companies are capitalizing on these advanced techniques. A case in point is Elanco Animal Health Incorporated, a US-based company producing veterinary pharmaceuticals and vaccines. In February 2022, they unveiled Increxxa, a newly approved medication for respiratory diseases in livestock. Administered by injection, Increxxa carries tulathromycin, which swiftly targets lung infection sites, providing rapid action and a long half-life. This gives cattle a better window to build a robust defense mechanism. This product, specifically designed for veterinary applications, uses tulathromycin as its active ingredient to mitigate the adverse consequences of bovine respiratory disease.
Who Are the Key Players in the Veterinary Anti-infectives Market?
Major companies operating in the veterinary anti-infectives market include:
• Bayer AG
• C. H. Boehringer Sohn AG & Co. KG
• Ceva Santé Animale
• Elanco Animal Health Incorporated
• Zoetis Inc.
• Vetoquinol S. A.
• Merck & Co.
• Phibro Animal Health
• Aspen Veterinary Resources Ltd.
• Bimeda Animal Health Limited
• Dechra Pharmaceuticals Plc
• Intervet International B. V.
• Oceanic Pharmachem Pvt. Ltd.
• Virbac Ltd.
• Indian Immunologicals Ltd. (IIL)
• Norbrook Laboratories Ltd.
• Ashish Life Science Pvt. Ltd.
• Kyoritsu Seiyaku Corporation
• Tianjin Ringpu Bio-Technology Co. Ltd.
• HIPRA
• Zydus Animal Health and Investments Limited
• China Animal Husbandry Group
• ZOOVETVARU Ltd.
• Magnum Veterinaaria Ltd.
• Inovet (V. M. D. nv/sa)
• Chanelle Pharmaceuticals Manufacturing Ltd.
• Huvepharma Inc.
• Veyx Pharma GmbH
• Biovet Pvt. Ltd.
• Laboratorios Ovejero SA
• Laboratorios Syva S. A.
What Is The Most Dominant Region In The Veterinary Anti-infectives Market?
North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
